Use of vitamin supplements and cataract: the Blue Mountains Eye Study.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 11438049)

Published in Am J Ophthalmol on July 01, 2001

Authors

M Kuzniarz1, P Mitchell, R G Cumming, V M Flood

Author Affiliations

1: Departments of Ophthalmology and Public Health & Community Medicine, the University of Sydney, Sydney, Australia.

Articles citing this

Identification of a major locus for age-related cortical cataract on chromosome 6p12-q12 in the Beaver Dam Eye Study. Proc Natl Acad Sci U S A (2004) 1.27

Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32. Ophthalmology (2011) 1.12

The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol (2006) 1.02

UV-B-induced damage to the lens in vitro: prevention by caffeine. J Ocul Pharmacol Ther (2008) 1.00

Evaluation of risk factors for cataract types in a competing risks framework. Ophthalmic Epidemiol (2009) 0.96

Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract. Cochrane Database Syst Rev (2012) 0.92

Nutrition effects on ocular diseases in the aging eye. Invest Ophthalmol Vis Sci (2013) 0.88

Role of 4-hydroxynonenal in epidermal growth factor receptor-mediated signaling in retinal pigment epithelial cells. Exp Eye Res (2010) 0.88

Ocular defects associated with a null mutation in the mouse arylamine N-acetyltransferase 2 gene. Mamm Genome (2007) 0.82

Plasma Homocysteine, Folate and Vitamin B(12) levels in senile cataract. Indian J Clin Biochem (2008) 0.81

Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye. J Ophthalmic Vis Res (2015) 0.79

Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women. Ophthalmic Epidemiol (2016) 0.77

Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease. J Ophthalmol (2015) 0.76

Genetic and Dietary Factors Influencing the Progression of Nuclear Cataract. Ophthalmology (2016) 0.75

The effect of multivitamin/mineral supplements on age-related cataracts: a systematic review and meta-analysis. Nutrients (2014) 0.75

Articles by these authors

Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol Rev Camb Philos Soc (1966) 17.89

Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (1987) 14.62

Interventions for preventing falls in elderly people. Cochrane Database Syst Rev (2003) 7.05

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82

Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med (1997) 6.09

Functions of the exosome in rRNA, snoRNA and snRNA synthesis. EMBO J (1999) 5.68

Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology (1996) 5.36

Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06

The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases. Genes Dev (1999) 4.95

Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc (1999) 4.35

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31

Acid-base titration across the membrane system of rat-liver mitochondria. Catalysis by uncouplers. Biochem J (1967) 4.24

Proton-coupled beta-galactoside translocation in non-metabolizing Escherichia coli. J Bioenerg (1972) 4.24

Estimation of membrane potential and pH difference across the cristae membrane of rat liver mitochondria. Eur J Biochem (1969) 3.97

Translocations through natural membranes. Adv Enzymol Relat Areas Mol Biol (1967) 3.77

Vectorial chemistry and the molecular mechanics of chemiosmotic coupling: power transmission by proticity. Biochem Soc Trans (1976) 3.58

Cooperative hernia study. Pain in the postrepair patient. Ann Surg (1996) 3.57

Performance and conservation of osmotic work by proton-coupled solute porter systems. J Bioenerg (1973) 3.41

Possible molecular mechanisms of the protonmotive function of cytochrome systems. J Theor Biol (1976) 3.41

Hip protectors in aged-care facilities: a randomized trial of use by individual higher-risk residents. Age Ageing (2001) 3.33

How best to fix a broken hip. Fractured Neck of Femur Health Outcomes Project Team. Med J Aust (1999) 3.25

Keilin's respiratory chain concept and its chemiosmotic consequences. Science (1979) 3.23

Translocation of some anions cations and acids in rat liver mitochondria. Eur J Biochem (1969) 3.13

The POP1 gene encodes a protein component common to the RNase MRP and RNase P ribonucleoproteins. Genes Dev (1994) 3.12

Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07

Interventions for preventing falls in elderly people. Cochrane Database Syst Rev (2001) 3.06

Chemiosmotic coupling in energy transduction: a logical development of biochemical knowledge. J Bioenerg (1972) 3.02

Proton-translocation phosphorylation in mitochondria, chloroplasts and bacteria: natural fuel cells and solar cells. Fed Proc (1967) 2.96

Mortality and morbidity after hip fracture: can evidence based clinical pathways make a difference? J Rheumatol (2000) 2.89

Proton/sodium ion antiport in Escherichia coli. Biochem J (1974) 2.89

Prevalence and causes of amblyopia in an adult population. Ophthalmology (1998) 2.84

Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ (2000) 2.79

Smoking and age-related macular degeneration: a review of association. Eye (Lond) (2005) 2.77

Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc (1999) 2.76

The polarity of proton translocation in some photosynthetic microorganisms. Eur J Biochem (1969) 2.74

Stoicheiometry of lactose-H+ symport across the plasma membrane of Escherichia coli. Biochem J (1973) 2.57

Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc (1998) 2.51

Degradation of ribosomal RNA precursors by the exosome. Nucleic Acids Res (2000) 2.47

Acid-base titration across the plasma membrane of Micrococcus denitrificans: factors affecting the effective proton conductance and the respiratory rate. J Bioenerg (1970) 2.45

Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J (2006) 2.34

The protonmotive Q cycle: a general formulation. FEBS Lett (1975) 2.32

Refractive errors in an older population: the Blue Mountains Eye Study. Ophthalmology (1999) 2.29

"Smoking is a major cause of blindness". Med J Aust (1999) 2.27

The Ninth Sir Hans Krebs Lecture. Compartmentation and communication in living systems. Ligand conduction: a general catalytic principle in chemical, osmotic and chemiosmotic reaction systems. Eur J Biochem (1979) 2.25

Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. Diabetologia (2010) 2.23

Hip protectors improve falls self-efficacy. Age Ageing (2000) 2.22

Stoichiometry of proton translocation through the respiratory chain and adenosine triphosphatase systems of rat liver mitochondria. Nature (1965) 2.19

Respiration-driven proton translocation in Micrococcus denitrificans. J Bioenerg (1971) 2.17

Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol (2009) 2.13

Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett (1975) 2.07

Knowledge and beliefs about common eye diseases. Aust N Z J Ophthalmol (1997) 2.06

Medications and cataract. The Blue Mountains Eye Study. Ophthalmology (1998) 2.05

Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol (2001) 2.00

Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol (2008) 1.98

Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA (1999) 1.96

British Medical Association enters GM-crop affray. Lancet (1999) 1.94

Vision screening for frail older people: a randomised trial. Br J Ophthalmol (2008) 1.93

Clustering of modified nucleotides at the functional center of bacterial ribosomal RNA. FASEB J (1993) 1.93

Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88

Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care (2001) 1.84

Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol (1998) 1.84

Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82

Retinopathy predicts coronary heart disease mortality. Heart (2008) 1.80

Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology (1997) 1.79

The development of performance and cost indicators for preschool immunisation. Arch Dis Child (1986) 1.77

Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol (1998) 1.70

Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci (1999) 1.70

Propofol and ECT. Br J Psychiatry (1992) 1.68

Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67

Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol (1996) 1.67

Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int (2000) 1.66

Vectorial chemiosmotic processes. Annu Rev Biochem (1977) 1.66

Incidence of nursing home placement in a defined community. Med J Aust (2001) 1.65

The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology (2000) 1.64

The nature of bipolar depression: implications for the definition of melancholia. J Affect Disord (2000) 1.64

Effects of cataract type and location on visual function: the Blue Mountains Eye Study. Eye (Lond) (2004) 1.62

Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms. Br J Surg (1983) 1.59

Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology (1999) 1.59

Covered expandable tracheal stents in the management of benign tracheal granulation tissue formation. Ann Thorac Surg (2000) 1.59

Proton translocation coupled to ATP hydrolysis in rat liver mitochondria. Eur J Biochem (1968) 1.57

Visual impairment, age-related cataract, and mortality. Arch Ophthalmol (2001) 1.55

Dairy consumption and overweight and obesity: a systematic review of prospective cohort studies. Obes Rev (2011) 1.54

Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol (1998) 1.53

Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52

Visual impairment and risk of hip fracture. Am J Epidemiol (2000) 1.51

Renal impairment and anaemia in a population-based study of older people. Intern Med J (2004) 1.51

Cystadenomas of the liver: a spectrum of disease. Can J Surg (2001) 1.51

The role of smart cards in France. Health Data Manag (1998) 1.49

Retinal microvascular changes and subsequent vascular events after ischemic stroke. Neurology (2011) 1.49

Synthesis of adenosine triphosphate by a protonmotive force in rat liver mitochondria. Nature (1966) 1.48

Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol (1999) 1.48

Chemiosmotic hypothesis of oxidative phosphorylation. Nature (1967) 1.47

Health status before and mortality after hip fracture. Am J Public Health (1996) 1.46